echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Antitumor Therapy > Shanghai Cancer Hospital: Professor Ye Dingwei's personal primary knife prostate cancer treatment surgery broke 3000 cases.

    Shanghai Cancer Hospital: Professor Ye Dingwei's personal primary knife prostate cancer treatment surgery broke 3000 cases.

    • Last Update: 2020-08-14
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    (Health Times reporter Wei Wei special correspondent Wang Guangchao/ Wen Liu Bing/Figure)
    . Recently, the reporter learned from Fudan University affiliated oncology hospital urology surgery was informed: 16 years in the establishment of the department, the leader of the department, Fudan University affiliated oncology hospital vice president, Fudan University Prostate Cancer Research Center Director Professor Ye Dingwei personal master knife completed the amount of prostate cancer treatment surgery exceeded 3000 cases, the team prostate cancer treatment surgery volume exceeded 4000 cases. The treatment volume of the center for several years in Shanghai area urinary and male reproductive system tumor diagnosis and treatment of the first, the overall surgical volume ranked among the highest in China, the efficacy of patient treatment reached the international advanced level.
    Professor Ye Dingwei and his team in China for the earliest multidisciplinary collaboration model (MDT) for the diagnosis and treatment of urinary and male reproductive system tumors, and he led the urology has become well-known at home and abroad urinary and male reproductive system tumor prevention, diagnosis, treatment and rehabilitation of the whole management center. Many original treatment measures were created, perfected, matured and extended to the whole country.
    in recent years, the urology department of Fudan University Affiliated Oncology Hospital has taken the lead in using Internet technology and artificial intelligence technology to improve the construction of "two platforms" - the first full-time management online platform covering urinary and male reproductive system tumor patients in China, the first cross-regional urinary tumor MDT online consultation platform. At the same time, with the advantage of "two platforms" to promote high-quality medical resources and technology sinking, so that the advanced diagnosis and treatment concepts and technology will serve a wider range of domestic urinary tumor patients.
    in addition to clinical treatment, since 2017, Ye Dingwei rate team in china to take the lead in the first time to start accurate screening for prostate cancer. The screening team entered seven communities in Shanghai, directly promoted the knowledge of prostate cancer prevention and treatment to the general public, and carried out prostate cancer screening for high-risk groups, a move that has been praised by the general population and established a feasible model for prostate cancer screening in China.
    Ye Dingwei said that 4000 cases of prostate cancer treatment is only a small goal, innovation, progress is always on the road. Therefore, as the chief expert of the urological tumor MDT team, he also presided over a remote MDT consultation with Zhongshan Hospital affiliated with Dalian Medical University, and trained the students of the short course for prostate cancer "into the forefront".
    .
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.